RxDoctor Payments Data

Jeffrey Odonnell, MD

Orthopaedic Surgery · Madison, WINPI 1073019675

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (34.4%), education and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 89.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $10,193 and has fallen 99.2% since, to $83 in 2025.

$16,951in general payments, 2019–2025

Across 36 payments — averaging $470.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$15K
  • Zimmer Biomet$523
  • Stryker$432
  • Johnson & Johnson$376
  • Orthalign Inc$282
  • Medical Device Business Services, Inc.$147

What the payments were for

  • Grants$5,83334%
  • Travel & lodging$2,09212%
  • Food & beverage$3,19319%
  • Education$5,83334%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,951 in reported general payments places this provider in the 80th percentile of 498 orthopaedic surgery providers in Wisconsin.

See all orthopaedic surgery providers in Wisconsin →

Medicare billing

Part B allowed, 2024
$36,100
Medicare patients
83
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl15$96
Pantoprazole Sodium16$94
Meloxicam36$85
Ondansetron OdtOndansetron15$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Madison

See the full list for Wisconsin →

Where these figures come from

Is this you, or does something look wrong? →